<p>Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo</p>
Jiaxuan Peng(Guangxi Medical University), Yu Qian(Shaoxing People's Hospital)
Cited by 23
Related Papers
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
|Bone Research|2021|52
Galangin suppresses human osteosarcoma cells: An exploration of its underlying mechanism
|Oncology Reports|2016|33
Dual protective role of velutin against articular cartilage degeneration and subchondral bone loss via the p38 signaling pathway in murine osteoarthritis
|Frontiers in Endocrinology|2022|10
<p>Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo</p>
|Drug Design Development and Therapy|2020|5